The pharmacodynamic and clinical trial evidence for statin dose

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

(2017) Simon D Harding et al.   NUCLEIC ACIDS RESEARCH

Cholesterol trials and mortality

(2016) John B. Warren et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Composite endpoints and the distortion of risk-benefit analysis

(2016) John B. Warren   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Cochrane corner: early statin therapy in acute coronary syndromes—what is the clinical benefit?

(2016) Alain Nordmann et al.   HEART

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

(2016) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

(2015) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin: winner in the statin wars, patients' health notwithstanding

(2015) S. Wolfe   BMJ-British Medical Journal

Rosuvastatin: winner in the statin wars, patients' health notwithstanding

(2015) S. Wolfe   BMJ-British Medical Journal

Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment

(2014) Tjeerd P. van Staa et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review

(2014) Mary A. De Vera et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

An assessment by the Statin Cognitive Safety Task Force: 2014 update

(2014) Carlos H. Rojas-Fernandez et al.   Journal of Clinical Lipidology

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Limit to Benefits of Large Reductions in Low-Density Lipoprotein Cholesterol Levels

(2013) Hisato Takagi   JAMA Internal Medicine

Long-Term Survival and Recurrence After Acute Myocardial Infarction in England, 2004 to 2010

(2012) Kate Smolina et al.  

Drug allergy

(2010) David A. Khan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

(2010)   LANCET

Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography

(2008) Christie M. Ballantyne et al.   CIRCULATION

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE